Table 2.
Case no. | Stage | Tumor type | IHC | FISH HER2/Chr 17 | Ratio DNA HER2/Gastrin N = 1–4 |
---|---|---|---|---|---|
1 | I | Endometrioid | 0 | 1.11 | 1.48 [0.12–3.48] N = 31 |
2 | I | Endometrioid | 0 | 1.20 | 0.63 [0.62–0.64] N = 2 |
3 | I | Papillary serous | 1 | 3.14 | 2.84 [0.47–5.20] N = 21 |
4 | I | Clear cell | 0 | 1.03 | 0.33 [–] N = 1 |
5 | I | Mucinous | 0 | 1.07 | 0.93 [0.66–1.36] N = 4 |
6 | I | Endometrioid | 0 | 1.19 | 0.61 [0.42–0.80] N = 2 |
7 | I | Mucinous | 0 | 1.22 | 0.20 [0.16–0.35] N = 3 |
8 | I | Endometrioid | 1 | 1.23 | 4.06 [0.94–7.40] N = 31 |
9 | I | Papillary mucinous | 0 | 1.43 | 0.49 [0.40–0.57] N = 3 |
10 | I | Endometrioid | 0 | 1.09 | 0.23 [0.10–0.53] N = 3 |
11 | I | Mucinous | 0 | 1.11 | 0.98 [0.47–1.68] N = 3 |
12 | I | Clear cell + serous | 2 | 1.65 | 0.75 [0.44–1.14] N = 3 |
13 | I | Clear cell | 0 | 1.74 | 0.23 [0.18–0.29] N = 3 |
14 | I | Serous | 0 | 1.11 | Not Det. |
15 | I | Clear cell | 1 | 1.32 | Not Det. |
16 | II | Serous | 0 | 1.10) | 0.56 [0.02–1.08] N = 4 |
17 | II | Clear cell + endometrioid | 0 | 7: 1.71 & 8: 1.22 | 1.09 [0.18–2.65] N = 31 |
18 | II | Endometrioid | 0 | ND | 0.92 [0.40–1.44] N = 2 |
19 | III | Papillary serous | 0 | 0.98 | 0.63 [0.30–0.75] N = 4 |
20 | III | Papillary serous | 1 | 1.13 | 8.10 [–] N = 1 |
21 | III | Endometrioid | 1 | 1.15 | 0.95 [0.53–1.36] N = 2 |
22 | III | Clear cell | 0 | 1.23 | 0.50 [0.07–1.28] N = 4 |
23 | III | Serous | 0 | 1.28 | 2.77 [0.90–6.81] N = 41 |
24 | III | Papillary serous | 0 | 1.46 | 2.95 [0.11–5.78] N = 21 |
25 | III | Endometrioid | 0 | 1.85 | 1.74 [1.36–2.48] N = 41 |
26 | III | Papillary serous | 0 | 0.62 | 0.27 [–] N = 1 |
27 | III | Endometrioid | 0 | 0.98 | 1.14 [0.83–1.65] N = 3 |
28 | III | Endometrioid | 0 | 1.18 | 1.00 [0.94–1.11] N = 4 |
29 | III | Serous + endometrioid | 1 | 1.25 | 2.97 [0.65–8.19] N = 41 |
30 | III | Endometrioid | 1 | 2.03 | 6.82 [0.94–16.33] N = 41 |
31 | III | Endometrioid | 2 | 1.22 | 1.82 [1.61–2.03] N = 21 |
32 | III | Endometrioid | 0 | 1.05 | ND |
33 | III | Endometrioid | 0 | 1.07 | ND |
34 | III | Serous | 0 | 1.2 | ND |
35 | III | Serous | 0 | 1.11 | ND |
36 | IV | Serous | 1 | 1.03 | 0.75 [–] N = 1 |
37 | IV | Serous | 0 | 1.17 | 0.78 [–] N = 1 |
38 | IV | Clear cell + serous | 1 | 1.28 | 3.51 [2.37–4.34] N = 2 |
39 | Mucinous | 1 | 1.15 | 6.21 [1.4–11.0] N = 21 | |
40 | IV | Endometrioid | 0 | 1.74 | ND |
FISH, fluorescence in situ hybridization; HER2, human epidermal growth factor receptor type 2; IHC, immunohistochemistry; ND, not determined; PCR, polymerase chain reaction.
The qPCR ratio between HER2 and gastrin has values both above and below cutoff.